Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D. Oct 31, 2022
Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022 Oct 20, 2022
Axogen to Participate in the 77th Annual Meeting of the American Society for Surgery of the Hand Sep 22, 2022
Axogen, Inc. Announces Organizational Updates, Preliminary Second Quarter Revenue and Reaffirms Full-Year 2022 Financial Guidance Jul 18, 2022
Axogen, Inc. to present at the Jefferies Virtual Healthcare Conference and the JMP Securities Life Sciences Conference May 18, 2022
Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft May 4, 2022
